德塞佩卢马布对患有严重,不受控制的喘患者的医疗利用的影响:NAVIGATOR研究
Andrew Menzies-Gow1, Arnaud Bourdin2, Geoffrey Chupp3
1Royal Brompton and Harefield Hospitals, School of Immunology & Microbial Sciences, King's College, London, United Kingdom.
概括
佩鲁马布显著减少了严重喘患者的医疗保健利用率. 这种生物疗法减少了住院治疗,急诊和专家咨询,减轻了整体疾病负担.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 一种单克隆抗体Tezepelumab的目标是胸膜层淋巴质素 (TSLP).
- 在NAVIGATOR研究中证明了tzepelumab在改善严重,不受控制的喘患者的肺功能和喘控制方面的有效性.
- 在这种患者群体中,特泽佩卢马布对医疗保健利用率 (HCU) 的影响仍然不太清楚.
研究的目的:
- 量化与喘相关的医疗保健利用率 (HCU) 的减少,与安慰剂相比,在接受tezepelumab治疗的患者中.
- 评估tzepelumab对需要住院治疗的喘恶化严重程度的影响.
主要方法:
- 在NAVIGATOR研究中,随机分配的患者每4周接受特泽佩卢马布或安慰剂,持续52周.
- 与喘相关的HCU事件从调查员报告的叙述系统地分析.
- 事件强度 (轻度,中度,严重) 被评估为与恶化相关的住院治疗.
主要成果:
- 与安慰剂相比,Tezepelumab显著减少了与喘相关的非预定专家访问,医疗保健提供者的呼叫,救护车运输,急诊室访问,住院和重症监护日.
- 接受tzepelumab治疗的患者与安慰剂 (82%) 相比,患有严重喘恶化相关的住院病例 (38%) 较少.
结论:
- 采佩卢马布在严重的,不受控制的喘中,在所有测量结果中大幅减少了医疗保健利用率.
- 佩鲁马布有效地减少了严重,不受控制的喘的整体负担,包括恶化的严重程度.
相关概念视频
01:19Antiasthma Drugs: Leukotriene Modifiers
379
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
379
01:30Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
01:30Asthma-IV: Nursing Management
3.2K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.2K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
361
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
361
01:24Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
01:20Asthma: Pathogenesis and Management
467
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
467